- Home
- LSB vs HKPD Comparison
LSB vs HKPD Comparison
Compare LSB & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- HKPD
- Stock Information
- Founded
- LSB 2002
- HKPD 2016
- Country
- LSB China
- HKPD Hong Kong
- Employees
- LSB N/A
- HKPD N/A
- Industry
- LSB
- HKPD Other Pharmaceuticals
- Sector
- LSB
- HKPD Health Care
- Exchange
- LSB NYSE
- HKPD Nasdaq
- Market Cap
- LSB 22.3M
- HKPD 20.9M
- IPO Year
- LSB N/A
- HKPD 2025
- Fundamental
- Price
- LSB $1.00
- HKPD $1.28
- Analyst Decision
- LSB
- HKPD
- Analyst Count
- LSB 0
- HKPD 0
- Target Price
- LSB N/A
- HKPD N/A
- AVG Volume (30 Days)
- LSB 24.2K
- HKPD 3.1M
- Earning Date
- LSB 07-07-2025
- HKPD 01-01-0001
- Dividend Yield
- LSB N/A
- HKPD N/A
- EPS Growth
- LSB N/A
- HKPD N/A
- EPS
- LSB N/A
- HKPD 0.21
- Revenue
- LSB $79,415,311.00
- HKPD $20,770,344.00
- Revenue This Year
- LSB $39.33
- HKPD N/A
- Revenue Next Year
- LSB $75.61
- HKPD N/A
- P/E Ratio
- LSB N/A
- HKPD $6.65
- Revenue Growth
- LSB N/A
- HKPD 32.91
- 52 Week Low
- LSB $0.36
- HKPD $0.81
- 52 Week High
- LSB $6.82
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- LSB 37.29
- HKPD N/A
- Support Level
- LSB $0.91
- HKPD N/A
- Resistance Level
- LSB $1.03
- HKPD N/A
- Average True Range (ATR)
- LSB 0.06
- HKPD 0.00
- MACD
- LSB 0.01
- HKPD 0.00
- Stochastic Oscillator
- LSB 43.75
- HKPD 0.00
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.